They’re Lying To You About How Keto Works! | Dr. Dominic D’Agostino
What if ketogenic dieting is closer to a metabolic therapy than a lifestyle, and most users are running it without the measurements that make it work?
Episode aired Dec 24, 2025·Page synthesised Apr 27, 2026·Last reviewed Apr 27, 2026
What this episode covers
- Dominic D'Agostino, a research scientist at the University of South Florida who has spent decades on ketogenic-diet biology, defines ketogenic eating as a metabolic therapy distinguished by measurable biomarkers (blood ketones, glucose-ketone index) rather than vague low-carb guidelines.
- He walks through the diet's history from clinical epilepsy treatment to broader metabolic and selected psychiatric and neurological applications.
- Emphasizes electrolyte management as critical for safety and adherence, and individualized biomarker tracking as the only way to confirm therapeutic ketosis.
- One of the more rigorous voices in ketogenic-diet research in popular health media.
Why it matters
Most popular ketogenic content treats keto as a vague low-carb diet. The actual therapeutic effect requires measurable ketosis (typically 0.5 to 3.0 mmol/L depending on the therapeutic goal), electrolyte management, and tracking. Without these, most 'keto' attempts produce neither the metabolic effect nor the measurable benefit.
What stands out
- Most 'keto' attempts in the wild are not actually achieving nutritional ketosis; they are low-carb without measurement.
- Electrolyte management, not carb cuts, is the variable that determines adherence in most attempts.
- Lipid response on ketogenic eating is highly individual; the metabolic improvements do not guarantee benign lipid changes for everyone.
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
If you decide to try ketogenic eating, treat it as a 4 to 6 week therapeutic trial with electrolyte management and a blood ketone meter, not as a lifestyle hack.
Where to start
Small low-friction starters covering the main moves from this episode.
- Plan a 4 to 6 week trial, not a permanent lifestyle.
- Get a blood ketone meter before starting.
- Replace electrolytes actively from day 1.
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Action: If you commit to a ketogenic trial, run it for 4 to 6 weeks with strict electrolyte management (3 to 5 g sodium, 200 to 400 mg magnesium, adequate potassium from leafy greens) and blood ketone tracking. Whether ketogenic eating is the right tool for your specific goal (vs moderate low-carb) depends on biomarkers, adherence capacity, and the specific application; most adults pursuing 'general health' do not need to go this aggressive. Limitation: Ketogenic eating is more demanding than moderate carb reduction. Adherence is the limiting factor. Fork: If full ketogenic feels unsustainable, low-carb (100 to 150 g/day) captures most benefits for most adults. Cost of Wrong: Running 'keto' without electrolyte management or biomarker tracking produces neither the metabolic effect nor measurable benefit; high dropout, no insight. Reinforce: When you run ketogenic eating as designed (measured, electrolyte-managed, time-bounded), it is one of the better-supported metabolic interventions for selected goals.Strong evidence
- Action: Track blood ketones at least weekly during a ketogenic trial; aim for 0.5 to 3.0 mmol/L beta-hydroxybutyrate, depending on the therapeutic goal. Limitation: Blood ketone meters and strips cost $1 to $2 per measurement; budget for it. Fork: Breath analyzers (e.g., Lumen-style devices) are reusable and cheaper per measurement but less precise. Cost of Wrong: Without measurement, you do not know if you achieved nutritional ketosis. 'Feeling keto' is unreliable. Reinforce: This is the difference between ketogenic eating as a measured therapy and ketogenic eating as a guess.Strong evidence
- Action: Monitor lipid response during and after a ketogenic trial. Get a lipid panel and ApoB measurement at baseline and 6 to 8 weeks in. Limitation: ApoB is not always a routine lab; you may need to specifically request it. Fork: If your LDL rises substantially on ketogenic eating, the next conversation is whether the metabolic improvements offset the lipid change for your specific cardiovascular risk profile. Cost of Wrong: Assuming all ketogenic-induced lipid changes are benign without measurement is one of the more documented mistakes; some users develop substantial elevations. Reinforce: This is the lab work that distinguishes informed ketogenic eating from cargo-cult ketogenic eating. Interpretation of lipid changes should be done in the context of overall cardiovascular risk, not in isolation.Strong evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my current health, would a 4 to 6 week ketogenic trial be reasonable, and what biomarkers should we track?
- Are there conditions in my history (kidney disease, gallbladder issues, eating disorder) that would change the calculation?
- If my LDL or ApoB rises on ketogenic eating, how should we interpret that against my other improvements?
- For my specific goal (weight loss, T2D, mental clarity), is ketogenic eating actually the right tool or is moderate low-carb sufficient?
Full doctor prep with ranked questions available in the full topic page
Context
The expert emphasizes translating research into actionable steps, focusing on what the evidence actually supports versus common assumptions.
Mainstream-supported: ketogenic diet for drug-resistant epilepsy, ketogenic diet for short-term metabolic improvement in T2D, electrolyte management as essential to adherence.
Likely true but more preliminary: psychiatric applications (treatment-resistant depression, bipolar disorder, schizophrenia).
What ketogenic eating does NOT prove: that it is the optimal long-term diet for healthy adults; that it outperforms moderate carb reduction at similar adherence; that the lipid changes are universally benign.
What the rigorous version does NOT replace: medical management of established conditions; clinician oversight for patients with cardiac, kidney, or metabolic comorbidities.
Long-term adherence and sustainability remain the primary limiting factors for most adults.
Where people go wrong
- Going 'keto' without measuring ketones.If you are not tracking ketones, you are doing low-carb (often badly), not ketogenic eating. The therapeutic effect requires measurable ketosis.
- Skipping electrolyte management.Most failed ketogenic attempts fail at electrolytes, not at carb cuts. The 'keto flu' is preventable but not avoidable without active sodium, potassium, and magnesium replacement.
What to expect over time
- Days 1 to 14Initial adaptation; possible 'keto flu' if electrolytes neglected. Energy and mental clarity often improve by end of week 2 if managed.
- Weeks 3 to 6Stable nutritional ketosis if adherence holds; weight loss and metabolic markers shift; lipid panel reveals individual response.
- Months 3 to 6Improved fat-oxidation capacity if sustained; reassess whether to continue, transition to moderate low-carb, or move on based on biomarkers and lifestyle fit.